Why It Makes Sense To Keep Avastin Available For Women With Metastatic Breast Cancer In late June, the Food and Drug Administration (FDA) held an unusual, open-door and emotionally-packed meeting of its Oncologic Drugs Advisory… Related Post navigation Previous: Looking Back on ‘The Normal Heart,’ and Patients’ ActivisimNext: Notes on Kris Carr and Crazy Sexy Cancer